Mergers and acquisitions, rising Japanese yen and the Judaic Day of Atonement: what do they mean for stocks? Art Cashin, director of floor operations at UBS Financial Services, offered CNBC his market insights.
Propelled by M&A activity and chatter, U.S. stock futures are up modestly this morning despite a sell-off in Asian markets overnight.
Futures swung to indicate a positive open for Wall Street on Monday, riding a wave of merger and acquisition activity and despite stocks in Europe and Asia falling.
As we approach another quarter and month end, with just four days to go, the Dow is on track for its best third quarter since 1939, the S&P is on course for its biggest Q3 gains since 1970, and the Nasdaq Composite is having its best Q3 since 1997, based on September 24 closing levels. Will the markets continue to hold on to gains or sell off by the end of the year?
James Hardesty at Hardesty Capital Management and Wayne Kaufman at John Thomas Financial weighed in on where to invest in a low-volume environment and what to watch next week.
The drug biz is abuzz over social media. It's the new frontier. For a lot of PR and corporate communications teams it's all about new media and social media. Some biopharmas, big and small, now have directors of social media. Most are still trying to find their way, but the Food and Drug Administration may soon direct them.
Charles Bobrinskoy, vice chairman and director of research at Ariel Investments and Marc Harris, co-head of Global Research at RBC Capital Markets shared their insights on where to invest in a low volume environment and what investors should be watching for next week.
3M has soared almost 80 percent since the March market low, and recently hit its 52-week high. Where's the stock headed? Deane Dray, senior diversified industrials analyst at FBR Capital Markets, shared his views on the company.
Stocks moved into positive territory Monday afternoon as tech, bank and drug stocks gained and volatility waned.
Stocks pared their losses Monday as President Obama's speech on financial reform had little impact on the market.
Stocks declined Monday as investors worried about a trade dispute between the US and China and reflected on the one-year anniversary of the Lehman Brothers collapse.
One year ago on Sunday September 14, Lehman Brothers was scrambling before declaring bankruptcy later that night and Bank of America announced a deal to acquire Merrill Lynch. Here is a look at where major indices and stocks look one year later.
Some analysts had been telling clients recently that they thought Vivus' diet drug Qnexa could take the lead in the three-contestant race to get the next prescription diet pill on the market. But they didn't think it would take such a commanding lead.
Warren Buffett always says he loves to go to work each day, and the global financial crisis has done nothing to damper that enthusiasm for his job. Buffett tells the New York Times that all the "drama" has made for an "incredibly interesting period in the last year and a half."
Events surrounding swine flu are unfolding rapidly. With so many new developments what's the trade?
There are two kinds of companies in the market – cyclical and secular. One of the most important moves in the game is knowing when to shift money from one to the other.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Boston Scientific has rallied back to its highest levels since last year's financial crisis and is scheduled to discuss a key defibrillator trial this morning, prompting one large investor to position for a potential decline.
Stocks rallied for the month of August but fell on Monday as concerns about the global economy weighed on Wall Street. What must you know about this market?
Are there any buying opportunities for investors on the horizon? Jeffrey Saut at Raymond James and Douglas Cliggott at Dover Management shared their market oulooks.
There is a pattern to recessions. Aggregate demand declines, employment falls, production slows, and the economy contracts. Central bankers, focused on price stability and maximum employment, add liquidity (credit) to the system to counter the decline and stimulate growth. Risky assets whose very survival may have been questioned at the economic nadir, rebound with remarkable flourish as their near-death experience becomes a distant memory.